Fuchs Dystrophy Latest Advances

Comment on "Efficacy of the Rho-Kinase Inhibitor for Corneal Endothelial Protection in Fuchs Endothelial Corneal Dystrophy after Phacoemulsification by Keeratidamkerngsakul et al."

Journal: Cornea

Published: March 31, 2026

Validation of a Regression Formula to Predict Post-DMEK Keratometry and Improve IOL Power Calculation in Eyes Undergoing Phacoemulsification Combined With DMEK.

Journal: Journal of refractive surgery (Thorofare, N.J. : 1995)

Published: March 07, 2026

The heterogeneity of Fuchs endothelial corneal dystrophy†.

Journal: The Journal of pathology

Published: March 02, 2026

TAZ (Wwtr1) deficiency leads to ER stress and mitochondrial dysfunction in a mouse model of Fuchs' endothelial corneal dystrophy.

Journal: bioRxiv : the preprint server for biology

Published: February 27, 2026

Genome-wide association study of corneal dystrophy uncovers novel risk loci and enables improved polygenic prediction of Fuchs endothelial corneal dystrophy.

Journal: medRxiv : the preprint server for health sciences

Published: February 23, 2026

Tissue-level heterogeneity in FECD: Descemet's membrane phenotypes and association with TCF4 CTG18.1 expansion†.

Journal: The Journal of pathology

Published: February 21, 2026

Fuchs Endothelial Corneal Dystrophy: A Post Hoc Analysis of the Women's Health Initiative Randomized Hormone Therapy Clinical Trials.

Journal: JAMA ophthalmology

Published: February 19, 2026

Non-diffractive EDOF IOL Implantation After Combined DMEK and Cataract Surgery.

Journal: Journal of refractive surgery (Thorofare, N.J. : 1995)

Published: February 10, 2026

Rare Association of Bilateral Central Salzmann Nodular Degeneration and Fuchs Endothelial Dystrophy Managed by DMEK: A Case Report.

Journal: Life (Basel, Switzerland)

Published: January 26, 2026

Early Transcriptomic and Pathologic Changes of Col8a2 Mutant Fuchs Endothelial Corneal Dystrophy.

Journal: Investigative ophthalmology & visual science

Published: January 23, 2026

The Prevalence of Fuchs' Endothelial Corneal Dystrophy in Cataract Patients within the Czech Population.

Journal: Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti

Published: January 21, 2026

Antioxidant Capacity in Fuchs' Dystrophy and Its Relationship with Cataract: A Pilot Study.

Journal: Journal of clinical medicine

Published: January 19, 2026

Fuchs Dystrophy Latest Advances

Find the Latest Research About Fuchs Dystrophy

Comment on "Efficacy of the Rho-Kinase Inhibitor for Corneal Endothelial Protection in Fuchs Endothelial Corneal Dystrophy after Phacoemulsification by Keeratidamkerngsakul et al."

Comment on "Efficacy of the Rho-Kinase Inhibitor for Corneal Endothelial Protection in Fuchs Endothelial Corneal Dystrophy after Phacoemulsification by Keeratidamkerngsakul et al."

Validation of a Regression Formula to Predict Post-DMEK Keratometry and Improve IOL Power Calculation in Eyes Undergoing Phacoemulsification Combined With DMEK.

Validation of a Regression Formula to Predict Post-DMEK Keratometry and Improve IOL Power Calculation in Eyes Undergoing Phacoemulsification Combined With DMEK.

The heterogeneity of Fuchs endothelial corneal dystrophy†.

The heterogeneity of Fuchs endothelial corneal dystrophy†.

TAZ (Wwtr1) deficiency leads to ER stress and mitochondrial dysfunction in a mouse model of Fuchs' endothelial corneal dystrophy.

TAZ (Wwtr1) deficiency leads to ER stress and mitochondrial dysfunction in a mouse model of Fuchs' endothelial corneal dystrophy.

Genome-wide association study of corneal dystrophy uncovers novel risk loci and enables improved polygenic prediction of Fuchs endothelial corneal dystrophy.

Genome-wide association study of corneal dystrophy uncovers novel risk loci and enables improved polygenic prediction of Fuchs endothelial corneal dystrophy.

Tissue-level heterogeneity in FECD: Descemet's membrane phenotypes and association with TCF4 CTG18.1 expansion†.

Tissue-level heterogeneity in FECD: Descemet's membrane phenotypes and association with TCF4 CTG18.1 expansion†.

Fuchs Endothelial Corneal Dystrophy: A Post Hoc Analysis of the Women's Health Initiative Randomized Hormone Therapy Clinical Trials.

Fuchs Endothelial Corneal Dystrophy: A Post Hoc Analysis of the Women's Health Initiative Randomized Hormone Therapy Clinical Trials.

Non-diffractive EDOF IOL Implantation After Combined DMEK and Cataract Surgery.

Non-diffractive EDOF IOL Implantation After Combined DMEK and Cataract Surgery.

Rare Association of Bilateral Central Salzmann Nodular Degeneration and Fuchs Endothelial Dystrophy Managed by DMEK: A Case Report.

Rare Association of Bilateral Central Salzmann Nodular Degeneration and Fuchs Endothelial Dystrophy Managed by DMEK: A Case Report.

Early Transcriptomic and Pathologic Changes of Col8a2 Mutant Fuchs Endothelial Corneal Dystrophy.

Early Transcriptomic and Pathologic Changes of Col8a2 Mutant Fuchs Endothelial Corneal Dystrophy.

The Prevalence of Fuchs' Endothelial Corneal Dystrophy in Cataract Patients within the Czech Population.

The Prevalence of Fuchs' Endothelial Corneal Dystrophy in Cataract Patients within the Czech Population.

Antioxidant Capacity in Fuchs' Dystrophy and Its Relationship with Cataract: A Pilot Study.

Antioxidant Capacity in Fuchs' Dystrophy and Its Relationship with Cataract: A Pilot Study.